Results 231 to 240 of about 991,500 (305)
In this study, we unveil a thymus‐brain endocrine axis wherein Tα1 engages HCRTR1 to inhibit RIPK3‐mediated necroptosis. This study nominates the Tal‐HCRTR1‐RIPK3 axis as a potent and clinically translatable therapeutic target for stroke and neurodegeneration.
Xinmei Kang +11 more
wiley +1 more source
Response to "Eleutheroembryo-based new approach methodologies for endocrine and metabolic endpoints: a comment on Christou et al. (2026)". [PDF]
Christou M +11 more
europepmc +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Glaucoma, a major cause of blindness, involves retinal ganglion cell (RGC) degeneration. This study shows growth hormone‐releasing hormone receptor (GHRHR) deficiency preserves RGC survival and restores vision, unlike activation which only aids survival.
Yan Tong +24 more
wiley +1 more source
Hormonal metabolic burden in diabetic retinopathy: the diabetic retina as an endocrine-responsive target organ. [PDF]
Chen J, Zhang L.
europepmc +1 more source
Direct ultrastructural validation of endocrine cell identity in zebrafish pancreatic islets. [PDF]
Schmitner N +6 more
europepmc +1 more source
Occupational cadmium exposure and endocrine biomarker alterations in male workers: a cross-sectional study. [PDF]
Özkan Vardar D +7 more
europepmc +1 more source

